Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
- PMID: 15851640
- DOI: 10.1001/archinte.165.8.891
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
Abstract
Background: The culture of bronchial secretions from the lower airway has been reported to be positive for potentially pathogenic microorganisms (PPMs) in patients with stable chronic obstructive pulmonary disease (COPD), but the determinants and effects of this bacterial load in the airway are not established.
Methods: To determine the bronchial microbial pattern in COPD and its relationship with exacerbation, we pooled analysis of crude data from studies that used protected specimen brush sampling, with age, sex, smoking, lung function, and microbiologic features of the lower airway as independent variables and exacerbation as the outcome, using logistic regression modeling.
Results: Of 337 study participants, 70 were healthy, 181 had stable COPD, and 86 had exacerbated COPD. Differences in the microbial characteristics in the participating laboratories were not statistically significant. A cutoff point of 10(2) colony-forming units (CFU) per milliliter or greater for the identification of abnormal positive culture results for PPMs was defined using the 95th percentile in the pooled analysis of healthy individuals. Bronchial colonization of 10(2) CFU/mL or greater by PPMs was found in 53 patients with stable COPD (29%) and in 46 patients with exacerbated COPD (54%) (P<.001, chi(2) test), with a predominance of Haemophilus influenzae and Pseudomonas aeruginosa. Higher microbial loads were associated with exacerbation and showed a statistically significant dose-response relationship after adjustment for covariates (odds ratio, 3.62; 95% confidence interval, 1.47-8.90), but P aeruginosa persisted as a statistically significant risk factor after adjustment for microbial load (odds ratio, 11.12; 95% confidence interval, 1.17-105.82).
Conclusions: One quarter of the patients with COPD are colonized by PPMs during their stable periods. Exacerbation is associated with the overgrowth of PPMs and with the appearance of P aeruginosa in the lower airway, which is associated with exacerbation symptoms independent of load.
Similar articles
-
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x. Respirology. 2007. PMID: 17207030
-
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.Respiration. 2007;74(1):19-25. doi: 10.1159/000093158. Epub 2006 May 3. Respiration. 2007. PMID: 16675894
-
[A clinical study of bacterial infection in patients with chronic obstructive pulmonary disease].Zhonghua Jie He He Hu Xi Za Zhi. 1999 Feb;22(2):88-91. Zhonghua Jie He He Hu Xi Za Zhi. 1999. PMID: 11820948 Chinese.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
[The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].Pol Merkur Lekarski. 2010 Apr;28(166):311-4. Pol Merkur Lekarski. 2010. PMID: 20491344 Review. Polish.
Cited by
-
Host-microbe interactions in distal airways: relevance to chronic airway diseases.Eur Respir Rev. 2015 Mar;24(135):78-91. doi: 10.1183/09059180.00011614. Eur Respir Rev. 2015. PMID: 25726559 Free PMC article. Review.
-
Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones.Clin Microbiol Infect. 2006 May;12 Suppl 3(Suppl 3):42-54. doi: 10.1111/j.1469-0691.2006.01396.x. Clin Microbiol Infect. 2006. PMID: 16669928 Free PMC article. Review.
-
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.Expert Rev Respir Med. 2011 Dec;5(6):809-21. doi: 10.1586/ers.11.76. Expert Rev Respir Med. 2011. PMID: 22082166 Free PMC article. Review.
-
Effectiveness of treatment with nebulized colistin in patients with COPD.Int J Chron Obstruct Pulmon Dis. 2017 Oct 5;12:2909-2915. doi: 10.2147/COPD.S138428. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29042767 Free PMC article.
-
Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection.PLoS One. 2013;8(1):e51784. doi: 10.1371/journal.pone.0051784. Epub 2013 Jan 22. PLoS One. 2013. PMID: 23349676 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical